Corbus Pharma

@CorbusPharma

Pioneering transformative medicines that target the endocannabinoid system (NASDAQ: )

Vrijeme pridruživanja: ožujak 2014.

Tweetovi

Blokirali ste korisnika/cu @CorbusPharma

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CorbusPharma

  1. prije 12 sati

    With a number of key milestones ahead, the Corbus Pharma team is excited for a transformative 2020.

    Poništi
  2. 4. velj

    Kristos discusses 's daily work environment: . Apply today to join our team!

    Poništi
  3. 3. velj

    Experts recently discussed the therapeutic potential of targeting the endocannabinoid system. Live webcast replay of the symposium hosted by is now available:

    Poništi
  4. 31. sij

    In an interview with , spoke about his management style and the importance of surrounding yourself with team players. Listen here:

    Poništi
  5. 30. sij

    . envisions a future where nobody with is left behind. We are all committed to advancing breakthroughs. View 's 2020 video:

    Poništi
  6. 30. sij

    is 1 month away! We are looking forward to spending the day with advocates and in Boston. Together, we are we working towards more equitable access to diagnosis, treatment, care & social opportunity for everyone living with a rare disease.

    Poništi
  7. proslijedio/la je Tweet
    28. sij

    Severe itch, burning, rashes . . Skin issues cause real pain, discomfort, and lower quality of life. Watch "Skin findings seen with myositis autoantibodies and treatment of skin in (DM)" w/ Dr. Victoria Werth

    Poništi
  8. 28. sij

    . comments on what makes the Corbus team unique: “The team we've assembled, collectively, has a knowledge base and an expertise base which I think really is quite out of the ordinary." via

    Poništi
  9. 27. sij

    "It's a daily living problem. You always feel very cold and have to have sweaters and mittens with you." Roberta Mauriello discusses daily life living with :

    Poništi
  10. 24. sij

    . reflects on the transformation Corbus has undergone in recent years and the company's continued growth. Listen to his interview with here:

    Poništi
  11. 24. sij

    “Every day I come to work I learn something new.” — Fannie Weaver discusses the work environment at . Check out our open roles today by visiting our website.

    Poništi
  12. 21. sij

    95 percent of rare diseases lack FDA-approved treatment? Learn how to raise awareness by participating in on 2/29:

    Poništi
  13. 20. sij

    Today, we honor the life and legacy of the great Martin Luther King Jr.

    Poništi
  14. 17. sij

    We are excited to attend the 2020 Annual Dinner in Waltham next month! This inspiring event brings together 350+ individuals dedicated to advancing research to celebrate successes and future goals. Learn more:

    Poništi
  15. 16. sij

    Experts recently discussed the therapeutic potential of targeting the endocannabinoid system. Live webcast replay of the symposium hosted by is now available:

    Poništi
  16. 15. sij

    Did you know that our is recruiting 150 people worldwide? Learn more:

    Poništi
  17. proslijedio/la je Tweet
    13. sij

    Are you at ? Meet us at RARE in the Square as we connect and collaborate to catalyze change in .

    Poništi
  18. 14. sij

    "Scleroderma has taught me to never give up and I guess I'm more aware of smaller things that are important in life. Keep fighting." Tricia and Tom Legere discuss navigating life with :

    Poništi
  19. proslijedio/la je Tweet
    13. sij

    ⁩ JPM2020 HQ is up and running!

    Poništi
  20. 13. sij

    We are thrilled to be back in San Francisco for a productive Healthcare Conference! We are excited to share progress on how we are achieving our goal of pioneering transformative medicines that target the endocannabinoid system.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·